EATG » Access

Access

HIV i-Base: HIV Treatment Bulletin, 9 February 2018

HIV Treatment Bulletin (HTB) is a community publication produced by HIV i-Base. The third issue of HTB for 2018 is now out. It features antiretroviral news, reviews of studies about…

For Venezuela HIV patients, lack of medicine ‘a death sentence’

Venezuela's economic crisis has left the country's health system on the verge of collapse. Amid a shortage of medication, HIV patients are succumbing to secondary infections, despite doctors' best efforts.…

Janssen HIV drug U.K. patent extension case to go to EU top court

Sandoz Ltd.’s lawsuit to clear the way for its generic version of the Prezista HIV drug will now go to the Court of Justice of the European Union. The England…

New data helps prioritise groups for HIV treatment in low resourced settings

Lancet study reveals for the first time who can benefit most from immediate antiretroviral treatment – enabling prioritisation in low-resourced settings. But who is left behind? A study published in…

Study on global trends in CD4 count at start of ART

Study finds more than half of patients worldwide don’t access HIV treatment until immune systems are severely compromised In spite of guidelines and goals, treatment access remains delayed and unequal…

Brussels gets into drug business

2018 is make-or-break for push to get countries to join up on prices. Few topics are more taboo in Brussels than the EU getting involved in drug pricing. Yet that’s exactly what the…

Kazakhstan community experts discussed the mechanisms for expanding access to the modern HIV treatment with the state officials

Representatives of patient communities, NGOs and state institutions of Kazakhstan, international agencies and organizations held a meeting on January 16 to discuss the results of the ART Availability Overview in…

Global summit on IP and access discusses impact of TRIPS-Plus measures on public health

A network of civil society organisations chose the birthplace of the World Trade Organization, Marrakesh, to hold a global summit on intellectual property and access to medicines this week. Part…

Factors associated with access to HIV testing and primary care among migrants living in Europe: cross-sectional survey

ABSTRACT Background There is a heavy and disproportionate burden of human immunodeficiency virus (HIV) infection among migrant communities living in Europe. Despite this, the published evidence related to HIV testing,…

Ireland: Gilead withdraws challenge to generic HIV drug

Gilead has dropped its appeal against the High Court’s refusal to grant an injunction against generic manufacturers Pharmaceutical giant Gilead, which manufactures the HIV anti-retroviral drug Truvada, has withdrawn its…